These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Buettner R, Mora LB, Jove R. Clin Cancer Res; 2002 Apr; 8(4):945-54. PubMed ID: 11948098 [Abstract] [Full Text] [Related]
23. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner GP, Silberman S, Hartman G, Micetich KC, Aranha GV, Alkan S. Anticancer Res; 2003 Apr; 23(3B):2253-60. PubMed ID: 12894500 [Abstract] [Full Text] [Related]
24. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation. Bai T, Luoh SW. Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906 [Abstract] [Full Text] [Related]
25. Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Sumita N, Bito T, Nakajima K, Nishigori C. Exp Dermatol; 2006 Apr; 15(4):291-9. PubMed ID: 16512876 [Abstract] [Full Text] [Related]
26. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H, Stephens LC, Kumar R. Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771 [Abstract] [Full Text] [Related]
27. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer. Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS. J Gene Med; 2005 Feb 01; 7(2):145-57. PubMed ID: 15546163 [Abstract] [Full Text] [Related]
28. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. Zhang X, Zhang J, Wang L, Wei H, Tian Z. BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579 [Abstract] [Full Text] [Related]
29. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Campbell CL, Jiang Z, Savarese DM, Savarese TM. Am J Pathol; 2001 Jan 04; 158(1):25-32. PubMed ID: 11141475 [Abstract] [Full Text] [Related]
30. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Zhang F, Li C, Halfter H, Liu J. Oncogene; 2003 Feb 13; 22(6):894-905. PubMed ID: 12584569 [Abstract] [Full Text] [Related]
31. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Clin Cancer Res; 2006 Sep 01; 12(17):5055-63. PubMed ID: 16951221 [Abstract] [Full Text] [Related]
32. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Lee JH, Schütte D, Wulf G, Füzesi L, Radzun HJ, Schweyer S, Engel W, Nayernia K. Hum Mol Genet; 2006 Jan 15; 15(2):201-11. PubMed ID: 16377660 [Abstract] [Full Text] [Related]
33. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL. Oncogene; 2002 Oct 31; 21(50):7611-8. PubMed ID: 12400004 [Abstract] [Full Text] [Related]
34. Signal transducer and activator of transcription-5 activation and breast cancer prognosis. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H. J Clin Oncol; 2004 Jun 01; 22(11):2053-60. PubMed ID: 15169792 [Abstract] [Full Text] [Related]
35. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Nishimoto A, Yu Y, Lu Z, Mao X, Ren Z, Watowich SS, Mills GB, Liao WS, Chen X, Bast RC, Luo RZ. Cancer Res; 2005 Aug 01; 65(15):6701-10. PubMed ID: 16061651 [Abstract] [Full Text] [Related]
36. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. Choi JH, Ahn MJ, Park CK, Han HX, Kwon SJ, Lee YY, Kim IS. APMIS; 2006 Sep 01; 114(9):619-25. PubMed ID: 16948814 [Abstract] [Full Text] [Related]
37. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA. Clin Cancer Res; 2006 Jan 01; 12(1):20-8. PubMed ID: 16397019 [Abstract] [Full Text] [Related]
38. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y, Sekikawa A, Kawada M, Suzuki K, Kayahara T, Fukui H, Sawada M, Chiba T. Oncogene; 2004 Jun 17; 23(28):4921-9. PubMed ID: 15077160 [Abstract] [Full Text] [Related]
39. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A. Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422 [Abstract] [Full Text] [Related]
40. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H. Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]